Familial meningioma: Analysis of expression of neurofibromatosis 2 protein Merlin

Journal of Neurosurgery

Volumn 88, Issue 3, 1998, Pages 562-569

  Maxwell, Marius ^a   Shih, Sarah D ^b   Galanopoulos, Theofanis ^b   Hedley Whyte, E Tessa ^b   Cosgrove, G Rees ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Familial tumor; Growth factor; Meningioma; Neurofibromatosis type 2; Protooncogene; Tumor suppressor gene; Tumorigenesis

Indexed keywords

GENE PRODUCT; MERLIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; FAMILIAL CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LAMINECTOMY; MALE; MENINGIOMA; NEUROFIBROMATOSIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0031918359     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.88.3.0562     Document Type: Article

References (49)

1. Antoniades HN, Galanopoulos T, Neville-Golden J, et al: Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50:215-222, 1992
2. Arakawa H, Hayashi N, Nagase H, et al: Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3:565-568, 1994
3. Bianchi AB, Hara T, Ramesh V, et al: Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6:185-192, 1994
4. Bishop JM: Molecular themes in oncogenesis. Cell 64: 235-248, 1991
5. Bolger GB, Stamberg J, Kirsch IR, et al: Chromosome translocation t(14;22) and oncogene (c-sis) variant in a pedigree with familial meningioma. N Engl J Med 312:564-567, 1985
6. Carstens C, Messe E, Zang KD, et al: Human KRAS oncogene expression in meningioma. Cancer Lett 43:37-41, 1988
7. Dumanski JP, Rouleau GA, Nordenskjöld M, et al: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50:5863-5867, 1990
8. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
9. Ferrante L, Mastronardi L, Acqui M, et al: Familial meningiomas. Report of two cases. J Neurosurg Sci 31:177-182, 1987
10. Gaist C, Piazza G: Meningiomas in two members of the same family (with no evidence of neurofibromatosis). J Neurosurg 16:110-113, 1959
11. Grunert V, Horcajada J, Sunder-Plassmann M: Familiäres Auftreten intrakranieller Meningeome. Wien Med Wochenschr 120:807-808, 1970
12. Hauge M, Harvald B: Studies in the etiology of intracranial tumours. Acta Psychiatr Neurol Scand 35:163-170, 1960
13. Huynh DP, Pulst SM: Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene 13:73-84, 1996
14. James CD, Carlbom E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546-5551, 1988
15. Joseph JT, Lisle DK, Jacoby LB, et al: NF2 gene analysis distinguishes hemangiopericytoma from meningioma. Am J Pathol 147:1450-1455, 1995
16. Joynt RJ, Perret GE: Familial meningiomas. J Neurol Neurosurg Psychiatry 28:163-164, 1965
17. Joynt RJ, Perret GE: Meningiomas in a mother and daughter. Cases without evidence of neurofibromatosis. Neurology 11: 164-165, 1961
18. Larson JJ, Tew JM Jr, Simon M, et al: Evidence for clo-nal spread in the development of multiple meningiomas. J Neurosurg 83:705-709, 1996
19. Lekanne Deprez RH, Riegman PHJ, Groen NA, et al: Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10:1521-1528, 1995
20. Lindblom A, Ruttledge M, Collins VP, et al: Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 56:354-357, 1994
21. Luna EJ, Hitt AL: Cytoskeleton-plasma membrane interactions. Science 258:955-964, 1992
22. Lutchman M, Rouleau GA: The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 55:2270-2274, 1995
23. Maxwell M, Galanopoulos T, Antoniades HN: Coexpression of EGFR and TGFα mRNA and protein occurs in primary meningiomas. Int J Oncol 9:917-922, 1996
24. Maxwell M, Galanopoulos T, Antoniades HN: Expression of cyclin D1 proto-oncogene mRNA in primary meningiomas may contribute to tumorigenesis. Int J Oncol 9:1213-1217, 1996
25. Maxwell M, Galanopoulos T, Hedley-Whyte ET, et al: Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer 46:16-21, 1990
26. Maxwell M, Galanopoulos T, Neville-Golden J, et al: Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78:456-462, 1993
27. Mehta D, Khatib R, Patel S, et al: Carcinoma of the breast and meningioma. Association and management. Cancer 51: 1937-1940, 1983
28. Memon MY: Multiple and familial meningiomas without evidence of neurofibromatosis. Neurosurgery 7:262-264, 1980
29. Mikkelsen T, Cairncross JG, Cavenee WK: Genetics of the malignant progression of astrocytoma. J Cell Biochem 46:3-8, 1991
30. Mirimanoff RO, Dosoretz DE, Linggood RM, et al: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18-24, 1985
31. Pulst SM, Rouleau GA, Marineau C, et al: Familial meningioma is not allelic to neurofibromatosis 2. Neurology 43: 2096-2098, 1993
32. Rempel SA, Schwechheimer K, Davis RL, et al: Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53: 2386-2392, 1993
33. Rouleau GA, Merel P, Lutchman M, et al: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521, 1993
34. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. Baltimore: Williams & Wilkins, 1989, pp 453-532
35. Ruttledge MH, Sarrazin J, Rangaratnam S, et al: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180-184, 1994
36. Sahar A: Familial occurrence of meningiomas. Case report. J Neurosurg 23:444-445, 1965
37. Sato N, Yonemura S, Obinata T, et al: Radixin, a barbed end-capping actin-modulating protein, is concentrated in the cleavage furrow during cytokinesis. J Cell Biol 113:321-330, 1991
38. Sedzimir CB, Frazer AK, Roberts JR: Cranial and spinal meningiomas in a pair of identical twin boys. J Neurol Neursurg Psychiatry 36:368-376, 1973
39. Seizinger BR, de la Monte S, Atkins L, et al: Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci USA 84:5419-5423, 1987
40. Sieb JP, Pulst SM, Buch A: Familial CNS tumors. J Neurol 239:343-344, 1992
41. Trofatter JA, MacCollin MM, Rutter JL, et al: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800, 1993
42. Twist EC, Ruttledge MH, Rousseau M, et al: The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151, 1994
43. Van Landegem W, Vakaet A, De Paepe A, et al: Familial meningioma. Case report with cytogenetic study. Clin Neurol Neurosurg 90:61-63, 1988
44. Wang JL, Nistér M, Hermansson M, et al: Expression of PDGF ß-receptors in human meningioma cells. Int J Cancer 46: 772-778, 1990
45. Wang JL, Zhang ZJ, Hartman M, et al: Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer 64:223-228, 1995
46. Wellenreuther R, Kraus JA, Lenartz D, et al: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827-832, 1995
47. Wieczorek V, Tinschert K, Behrendt W, et al: Familiäres Auftreten von multiplen, vorwiegend spinalen Meningiomen. Nervenarzt 63:244-246, 1992
48. Zhao JF, Sharma S: Expression of the ROS1 oncogene for tyrosine receptor kinase in adult human meningiomas. Cancer Genet Cytogenet 83:148-154, 1995
49. Zulch KJ: Histological Typing of Tumors of the Central Nervous System. International Histological Classification of Tumors. Geneva: World Health Organization, 1979